Phase I Clinical Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of LYN101
Clinical trial NCT07178327 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07178327
- Sponsor
- Shanghai TTM-Bio Technology Co., Ltd
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-06
- Primary completion
- 2026-09-06
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.